Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Study the Factors Affecting Treatment Responses in Patients With Uterine Cervical Carcinoma Undergoing Neoadjuvant Chemotherapy

NCT05384366 is registered in ClinicalTrials.gov with Banaras Hindu University as lead sponsor.

NCT NCT05384366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05384366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Study the Factors Affecting Treatment Responses in Patients With Uterine Cervical Carcinoma Undergoing Neoadjuvant Chemotherapy
Lead sponsor
Banaras Hindu University
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2020
Completion date
March 31, 2022
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the uterine cervix, cervical cancer, cervix cancer